Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort.
Falk SteffenTimo UphausNina RipfelVinzenz FleischerMuriel SchraadGabriel Gonzalez-EscamillaSinah EngelSergiu GroppaFrauke ZippStefan BittnerPublished in: Neurology(R) neuroimmunology & neuroinflammation (2022)
status at 6-year follow-up.